The Utrecht Pharmacy Practice network for Education and Research: A network of community and hospital pharmacies in the Netherlands

International Journal of Clinical Pharmacy

Volumn 36, Issue 4, 2014, Pages 669-674

  Koster, Ellen S ^a   Blom, Lyda ^a   Philbert, Daphne ^a   Rump, Willem ^a   Bouvy, Marcel L ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Pharmacy practice; Research network; The Netherlands; UPPER

Indexed keywords

ARTICLE; CLINICAL PRACTICE; HOSPITAL PHARMACY; HUMAN; MEDICAL EDUCATION; MEDICAL RESEARCH; NETHERLANDS; PHARMACY; PHARMACY PRACTICE; PRESCRIPTION; PRIORITY JOURNAL; UNIVERSITY; UNIVERSITY STUDENT; CLINICAL PHARMACOLOGY; COMMUNITY CARE; EDUCATION; HEALTH SERVICE; MANPOWER; PROCEDURES; TRENDS;

BIOMEDICAL RESEARCH; COMMUNITY NETWORKS; HUMANS; NETHERLANDS; PHARMACIES; PHARMACOLOGY, CLINICAL; PHARMACY RESIDENCIES; PHARMACY SERVICE, HOSPITAL; URBAN HEALTH SERVICES;

EID: 84905916646     PISSN: 22107703     EISSN: 22107711     Source Type: Journal    
DOI: 10.1007/s11096-014-9954-5     Document Type: Article

References (18)

1. van Mil JW. Pharmaceutical care in community pharmacy: practice and research in the Netherlands. Ann Pharmacother. 2005;39(10):1720-5.
2. Mays GP, Hogg RA, Castellanos-Cruz DM, Hoover AG, Fowler LC. Public health research implementation and translation: evidence from practice-based research networks. Am J Prev Med. 2013;45(6):752-62.
3. Marinac JS, Kuo GM. Characterizing the American college of clinical pharmacy practice-based research network. Pharmacotherapy. 2010;30(8):865.
4. Goode JV, Mott DA, Chater R. Collaborations to facilitate success of community pharmacy practice-based research networks. J Am Pharm Assoc (2003). 2008;48(2):153-62.
5. Pruchnicki MC, Rodis JL, Beatty SJ, Clark C, McAuley JW, Mehta BW, et al. Practice-based research network as a research training model for community/ambulatory pharmacy residents. J Am Pharm Assoc (2003). 2008;48(2):191-202.
6. Peterson GM, Jackson SL, Fitzmaurice KD, Gee PR. Attitudes of Australian pharmacists towards practice-based research. J Clin Pharm Ther. 2009;34(4):397-405.
7. Hebert J, Laliberte MC, Berbiche D, Martin E, Lalonde L. The willingness of community pharmacists to participate in a practice-based research network. Can Pharm J (Ott). 2013;146(1):47-54.
8. Koster ES, Walgers JC, van Grinsven MC, Winters NA, Bouvy ML. Adherence to national recommendations for safe methotrexate dispensing in community pharmacies. J Manag Care Pharm. 2014;20(2):194-200.
9. van Geffen EC, van Hulten R, Bouvy ML, Egberts AC, Heerdink ER. Characteristics and reasons associated with nonacceptance of selective serotonin-reuptake inhibitor treatment. Ann Pharmacother. 2008;42(2):218-25. (Pubitemid 351238570)
10. Zuidgeest MG, Koster ES, Maitland-van der Zee AH, Smit AH, Brunekreef B, Leufkens HG, et al. Asthma therapy during the first 8 years of life: a PIAMA cohort study. J Asthma. 2010;47(2):209-13.
11. Floor-Schreudering A, De Smet PA, Buurma H, Egberts AC, Bouvy ML. Documentation quality in community pharmacy: completeness of electronic patient records after patients' first visits. Ann Pharmacother. 2009;43(11):1787-94.
12. Koster ES, Raaijmakers JA, Koppelman GH, Postma DS, van der Ent CK, Koenderman L, et al. Pharmacogenetics of anti-inflammatory treatment in children with asthma: rationale and design of the PACMAN cohort. Pharmacogenomics. 2009;10(8):1351-61.
13. Fietje EH, Philbert D, van Geffen EC, Winters NA, Bouvy ML. Adherence to oseltamivir guidelines during influenza pandemic, the Netherlands. Emerg Infect Dis. 2012;18(3):534-5.
14. Koster ES, Blom L, Winters NA, van Hulten RP, Bouvy ML. Interpretation of drug label instructions: a study among four immigrants groups in the Netherlands. Int J Clin Pharm. 2014;36(2):274-81.
15. Floor-Schreudering A, Smet PA, Buurma H, Kramers C, Tromp PC, Belitser SV, et al. NSAID-antihypertensive drug interactions: which outpatients are at risk for a rise in systolic blood pressure? Eur J Prev Cardiol. 2013; september 16 [Epub ahead of print].
16. Wouters H, van Geffen EC, Baas-Thijssen MC, Krol-Warmerdam EM, Stiggelbout AM, Belitser S, et al. Disentangling breast cancer patients' perceptions and experiences with regard to endocrine therapy: nature and relevance for non-adherence. Breast. 2013;22(5):661-6.
17. Wouters H, Maatman GA, Van Dijk L, Bouvy ML, Vree R, van Geffen EC, et al. Trade-off preferences regarding adjuvant endocrine therapy among women with estrogen receptor-positive breast cancer. Ann Oncol. 2013;24(9):2324-9.
18. Holsappel IG, Koster ES, Winters NA, Bouvy ML. Prescribing with indication: uptake of regulations in current practice and patients opinions in the Netherlands. Int J Clin Pharm. 2014;36(2):282-6.